NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • NIHR Imperial BRC Primary Care Research Unit (PCRU)
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Treatment Stories

Treatment Peanut allergy vaccine has the potential to transform allergy care

Treatment Peanut allergy vaccine has the potential to transform allergy care

Published on 6th February 2025
PreventionTreatment Study links COVID-19 to biomarkers for abnormal brain proteins

PreventionTreatment Study links COVID-19 to biomarkers for abnormal brain proteins

Published on 30th January 2025
Treatment Research emphasises the need for COVID-19 protection for immunosuppressed people

Treatment Research emphasises the need for COVID-19 protection for immunosuppressed people

Published on 24th January 2025
PreventionTreatment New funding to investigate the development of resistance to flu

PreventionTreatment New funding to investigate the development of resistance to flu

Published on 22nd January 2025
Treatment Immune system can destroy ‘zombie’ cancer cells when SMARCA4 protein is inhibited

Treatment Immune system can destroy ‘zombie’ cancer cells when SMARCA4 protein is inhibited

Published on 21st January 2025
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Treatment New Study Explores Vaccine Effectiveness for Inflammatory Bowel Disease
  • Prevention Detection of Asymptomatic Malaria Cases Using Rapid Diagnostic Tools
  • DiagnosticPrevention St Mary’s Pilots Rapid Blood Test to Detect Life-Threatening Conditions in Children
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre